Valuation: Virbac

Market Cap 2.78B 3.18B 2.56B 2.38B 4.52B 303B 4.59B 30.69B 11.93B 149B 11.94B 11.69B 513B P/E 2026 *
16.6x
P/E 2027 * 14.7x
Enterprise Value 2.9B 3.32B 2.67B 2.49B 4.72B 316B 4.79B 32.02B 12.45B 155B 12.46B 12.19B 535B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.71x
Free-Float
49.03%
Yield 2026 *
0.52%
Yield 2027 * 0.62%
1 day+0.15%
1 week-2.92%
Current month-0.15%
1 month-2.64%
3 months-5.41%
6 months-6.08%
Current year-7.13%
1 week 327.5
Extreme 327.5
347
1 month 327.5
Extreme 327.5
359
Current year 326.5
Extreme 326.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Date Insider Type Main position Quantity % Market Cap.
24-04-21Sell

Chief Executive Officer

1,688 0.0200%
24-04-21Sell

Chief Executive Officer

810 0.0096%
24-04-21Sell

Chief Executive Officer

140 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%-2.92%-3.91%+22.51% 3.18B
+3.24%-1.70%-53.01%-56.06% 31.36B
+3.78%+1.75%+70.77%+149.25% 12.49B
+1.56%-4.08%-13.04%+5.09% 3.84B
+2.93%+7.60%+53.68%+27.83% 1.98B
+0.50%+2.89%-27.86%+18.36% 1.66B
+3.61%+4.95%+18.79%+141.72% 1.35B
+2.74%+9.39%-20.52%-11.63% 1.05B
-1.39%-2.21%-6.23%-23.04% 941M
+2.29%+5.22%-15.20%-47.08% 940M
Average +1.94%+2.02%+0.35%+22.69% 5.88B
Weighted average by Cap. +2.90%-0.82%-13.56%+6.73%

Financials

2026 *2027 *
Net sales 1.55B 1.77B 1.42B 1.32B 2.51B 168B 2.55B 17.06B 6.63B 82.79B 6.64B 6.5B 285B 1.64B 1.88B 1.51B 1.4B 2.66B 179B 2.7B 18.09B 7.03B 87.78B 7.04B 6.89B 302B
Net income 167M 191M 153M 143M 271M 18.19B 275M 1.84B 716M 8.94B 717M 702M 30.81B 190M 218M 175M 163M 309M 20.72B 314M 2.1B 816M 10.18B 817M 799M 35.09B
Net Debt 121M 138M 111M 104M 197M 13.18B 200M 1.33B 519M 6.48B 520M 508M 22.32B 26.49M 30.3M 24.35M 22.69M 43.04M 2.89B 43.7M 292M 114M 1.42B 114M 111M 4.89B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-07-03 €332.00 +0.15% 3,366
26-07-02 €331.50 +0.45% 6,240
26-07-01 €330.00 -0.75% 5,366
26-06-30 €332.50 -1.92% 6,550
26-06-29 €339.00 -0.88% 3,278
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
332.00EUR
Average target price
412.88EUR
Spread / Average Target
+24.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock